PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27171518-7	2016	RESULTS: Certolizumab treatment significantly decreased the serum levels of amylase, lipase, and lactate dehydrogenase.	Certolizumab Pegol	9-21	lipase G, endothelial type	Rattus norvegicus	85-91	
30892445-8	2019	RESULTS: Certolizumab treatment significantly decreased serum amylase, lipase, and LDH levels; histopathologically edema, hemorrhage, parenchymal necrosis, fat necrosis, and infiltration scores; immunohistochemically MDA, MPO, TNF-alpha and Caspase-3 activity.	Certolizumab Pegol	9-21	lipase G, endothelial type	Rattus norvegicus	71-77